VolitionRx Limited (NYSE:NYSE:VNRX) Q2 2022 Earnings Conference Call August 11, 2022 08:30 AM ET Company Participants Scott Powell - IR Cameron Reynolds - CEO Dr.
VolitionRx (NYSE-A:VNRX) Limited ended the second quarter with $16.7 million in the bank to help advance research and commercialization efforts for its.
Banxa Holdings Inc has announced that its founder and chairman, Domenic Carosa, will be attending the Q3 Virtual Investor Summit on August 16 and 17, 2022,.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June.
/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced it will host a conference call on Thursday August 11, at 08.30 a.m..